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A B S T R A C T
Risk assessment, environmental monitoring, and the disinfection of water systems are the key elements in
preventing legionellosis risk.
The Italian Study Group of Hospital Hygiene of the Italian Society of Hygiene, Preventive Medicine, and
Public Health and the Italian Multidisciplinary Society for the Prevention of Health Care-Associated Infections
carried out a national cross-sectional survey to investigate the measures taken to prevent and control legio-
nellosis in Italian hospitals.
A multiple-choice questionnaire was developed, comprising 71 questions regarding hospital location, general
characteristics, clinical and environmental surveillance, and control and preventive measures for legionellosis in
2015. Overall, 739 hospitals were enrolled from February to June 2017, and 178 anonymous questionnaires
were correctly completed and evaluated (response rate: 24.1%). The survey was conducted using the
SurveyMonkey® platform, and the data were analyzed using Stata 12 software.
Of the participating hospitals, 63.2% reported at least one case of legionellosis, of which 28.2% were of
proven nosocomial origin. The highest case numbers were reported in the Northern Italy, in hospitals with a
pavilion structure or cooling towers, and in hospitals with higher numbers of beds, wards and operating theaters.
Laboratory diagnosis was performed using urinary antigen testing alone (31.9%), both urinary antigen testing
and single antibody titer (17.8%), or with seroconversion also added (21.5%). Culture-based or molecular in-
vestigations were performed in 28.8% and 22.1% of the clinical specimens, respectively.
The water systems were routinely tested for Legionella in 97.4% of the hospitals, 62% of which detected a
positive result (> 1000 cfu/L). Legionella pneumophila serogroup 2–15 was the most frequently isolated species
(58.4%). The most common control measures were the disinfection of the water system (73.7%), mostly through
thermal shock (37.4%) and chlorine dioxide (34.4%), and the replacement (69.7%) or cleaning (70.4%) of
faucets and showerheads.
A dedicated multidisciplinary team was present in 52.8% of the hospitals, and 73% of the hospitals performed
risk assessment. Targeted training courses were organized in 36.5% of the hospitals, involving nurses (30.7%),
physicians (28.8%), biologists (21.5%), technicians (26.4%), and cleaners (11%).
Control and prevention measures for legionellosis are present in Italian hospitals, but some critical aspects
should be improved. More appropriate risk assessment is necessary, especially in large facilities with a high
number of hospitalizations. Moreover, more sensitive diagnostic tests should be used, and dedicated training
courses should be implemented.
1. Introduction
The genus Legionella includes Gram-negative microorganisms living
in natural and artificial water systems. These microorganisms are able
to grow at 25–50°C, especially in backwater systems. Infected sources
(e.g., faucets, showerheads, or cooling towers) can spread spray or
droplets of water containing Legionella, leaving airborne particles of less
than 5 µm in diameter that can be deeply inhaled.
These microorganisms can cause a severe form of pneumonia,
known as Legionnaires’ disease (LD), or a flu-like illness, the Pontiac
fever, which is normally acquired by inhaling contaminated particles
suspended in air (Montagna et al., 2006, 2014, 2017a; Rota et al.,
2013). To date, about 60 species of Legionella are known. Legionella
pneumophila (Lpn) is the species most frequently associated with human
disease and includes 16 serogroups (sg). Though the literature states
that Lpn sg 1 is the most common isolate in humans, an increasing
number of cases are being attributed to other Legionella species and
serogroups (ECDC, 2015; Napoli et al., 2010).
The association between potable water and nosocomial legionellosis
was described for the first time approximately 40 years ago (Tobin
et al., 1980). The complexity of hospitals’ water systems and the vul-
nerability of hospitalized patients increase the risk for Legionella
transmission and severe outcomes. A review of 27 LD outbreaks in-
vestigated by the Centers for Disease Control and Prevention from 2000
to 2014 indicated that health care-associated LD accounted for 33% of
the outbreaks, 57% of the outbreak-associated cases, and 85% of the
outbreak-associated deaths (Garrison et al., 2016; Soda et al., 2017).
Only one case of probable person-to-person transmission has been re-
ported (Correia et al., 2016). Currently, the hot water system is thought
to be the most frequent source of cases or outbreaks of LD in hospitals
(Borella et al., 2008; Montagna et al., 2017b; Napoli et al., 2010).
In Italy, according to the National Surveillance System for LD, the
number of cases has been steadily increasing, from 192 cases in 2000 to
1710 cases in 2016. Most of these cases are community-acquired, fol-
lowed by those that are travel-associated and then those that are as-
sociated with health care (5.3% in 2015). Overall, the case fatality rate
in Italy ranges from 8% to 17% (ISS, 2016; Rota et al., 2013). Clinical
outcomes are affected by comorbidities, with mortality ranging from
40% to 80% among untreated immunocompromised patients, and from
5% to 30% with appropriate therapy (ISS, 2016; Rota et al., 2013).
In 2000, the Italian Institute of Health issued its first guidelines for
the prevention and control of legionellosis. These were followed by
instructions for laboratories involved in microbiological diagnosis, en-
vironmental control, tourist accommodation, and spas in 2005. In 2015,
all of the national recommendations, including those for hospitals, were
incorporated in a single updated document (Linee, 2015). These in-
structions list risk assessment evaluation as one of the most effective
prevention measures to manage Legionella spp. contamination in water
systems. This is particularly relevant in hospitals because, in addition to
the water system, health practices concerning the airways (e.g., venti-
lation, aspiration, devices for artificial respiration and oxygen therapy,
and dental tools) can increase the risk of infection (Castiglia et al.,
2008; Pasquarella et al., 2010, 2012; Montagna and De Giglio, 2018).
Nevertheless, the control and prevention of legionellosis remain critical
issues in Italian health care settings. These guidelines are considered
reference documents and not compulsory protocol for prevention, and
very little is known about their implementation.
In light of this situation, the Italian Study Group of Hospital Hygiene
of the Italian Society of Hygiene, Preventive Medicine, and Public
Health (GISIO-SItI) and the Italian Multidisciplinary Society for the
Prevention of Health Care-Associated Infections (SIMPIOS) conducted a
national survey to i) collect information about specific measures for
legionellosis control and prevention adopted in Italian hospitals; ii)
identify the critical aspects of LD control and prevention; and iii) plan
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targeted corrective measures, where necessary.
2. Material and methods
2.1. Study design
After consulting the members of the GISIO-SItI and SIMPIOS
working groups in 2016, each working group developed a list of hos-
pitals in its own region and contacted the medical management of each
hospital by e-mail to request their participation in the study. Hospitals
in all regions of Italy were invited to take part in the study on a vo-
luntary basis and without remuneration. After having given their verbal
informed consent (as required by Italian privacy law), each participant
was asked to complete an anonymous questionnaire. The 71 item
questionnaire was divided into six sections, collecting data on location
and general structural characteristics of hospital, clinical and environ-
mental surveillance, and control and preventive measures for legio-
nellosis in 2015. To assess the accuracy of the questionnaire, an internal
pre-validation procedure was carried out at the University of Bari Aldo
Moro, involving 10 regional hospitals (Cronbach's alpha=0.71, in-
dicating good internal consistency).
The survey was conducted from February to June 2017, using
SurveyMonkey® software to facilitate archiving and data processing.
This study followed the principles of the World Medical Association
Declaration of Helsinki and does not report the results of any experi-
ment on humans or human samples, or research on identifiable human
material or data.
2.2. Clinical and environmental surveillance for Legionella
A brief description of the main tests investigated in the
questionnaire and regarding the clinical and environmental surveil-
lance of legionellosis is shown below.
2.2.1. Urine antigen test
This test uses monoclonal antibodies that recognize most Lpn sg 1
lipopolysaccharide antigens. It, however, fails to detect disease caused
by other serogroups of Lpn or other species of Legionella (Pierre et al.,
2017). Approximately 8% of patients with LD do not excrete antigen
(Munoz et al., 2009). The sensitivity and specifcity range from 69% to
100% and 99–100% respectively (Shimada et al., 2009).
2.2.2. Culture of respiratory tract
Culture can identify all of the known Legionella species and ser-
ogroups. The sensitivity and specificity of culture on selective media is
81% and 99%, respectively (Lindsay et al., 2004). A positive result
usually appears within 3–5 days, although 2 weeks may be required
because additional treatment, necessary to reduce background flora
that can inhibit the growth of Legionella.
2.2.3. Serological tests
Of the various antibody detection methods, indirect immuno-
fluorescence assays (IFA) and enzyme-linked immunosorbent assays
(ELISA) are the most commonly used ones. A fourfold or greater in-
crease in the titer of antibody is considered diagnostic. The reported
sensitivities of serological assays vary substantially, from 41% to 94%
(Boshuizen et al., 2003; den Boer and Yzerman, 2004).
2.2.4. Molecular tests
Commercially-available kits for PCR/RT-PCR for respiratory tract
specimens have sensitivities ranging from 17% to 100% and specifi-
cities ranging from 95% to 100% (Diederen et al., 2008; Benitez and
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Fig. 1. Correlation between legionellosis cases in 2015 and hospitals’ general characteristics.
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Winchell, 2013). Genus probes and Lpn probes have been developed,
but results rarely identify specific species or serogroups. PCR can be
performed in a few hours, but laboratory expertise is required.
2.2.5. Environmental surveillance
Water contamination was monitored according to the procedures
reported in the Italian Guidelines for the Prevention and Control of
Legionellosis (Linee, 2015).
Air contamination was assessed by the active and passive sampling.
Active sampling was performed by Surface Air System (SAS, PBI
International, Milan, Italy). The number of colony forming units was
adjusted using the conversion table provided by the manufacturer, and
was expressed in colony forming units per cubic meter (cfu/m3)
(Montagna et al., 2017a). Passive sampling was performed to determine
the Index of Microbial Air Contamination (IMA) (Pasquarella et al.,
2000), corresponding to the number of CFU counted on a Petri dish
with a diameter of 9 cm.
2.3. Statistical analysis
Because Gaussian distributions could not be assumed, continuous
variables were summarized using medians and interquartile ranges.
Non-parametric Mann–Whitney U and Kruskal–Wallis tests were used
to compare legionellosis cases by different categories of the collected
variables. Correlations between the cases of legionellosis and the col-
lected information were calculated using the Spearman correlation
coefficient. A p-value< 0.05 was regarded as statistically significant.
All analyses were conducted using the statistical software Stata 12.
3. Results
The study involved 739 Italian hospitals who were invited to par-
ticipate. A total sample of 195 anonymous questionnaires from 195
different hospitals was collected (response rate: 26.4%). Only the cor-
rectly completed questionnaires (n=178) were included in the ana-
lysis. No data were available on the non-participating hospitals. The
professional figures who replied to the questionnaire were health
management doctors (67.4%), nurses (17.8%), microbiologists (4.4%),
risk managers (3.7%), infectious diseases doctors (3.7%) and health
workers (3%).
3.1. General characteristics of the health care facilities
The 178 hospitals included in the study were located in the
Northern (60.7%), Central (12.9%), and Southern (26.4%) regions of
Italy. The sample included both public (79.8%) and private (20.2%)
hospitals. The age of the hospital buildings was as follows: over 60
years (23.9%), from 20 to 60 years (55.2%), under 20 years (20.9%).
The hospitals were generally structured as a single-building structure
(44.7%), a pavilion (21.4%), or both (34%), and most occupied mul-
tiple floors (up to 14).
More than 30 wards were found in 20.9% of the hospitals (range:
1–93 wards), and 36.8% had more than 10 operating theaters (range:
0–48). Most of the hospitals (60.8%) had fewer than 300 beds, 23.9%
had from 300 to 500 beds, and 15.4% had more than 500 beds (range:
21–1455). Cooling towers were present at 46.9% of the hospitals,
42.9% had maternity bathtubs, and 20.3% had ornamental fountains.
3.2. Clinical surveillance
In 2015, 63.2% of the hospitals reported at least one case of legio-
nellosis, of which 28.2% were of nosocomial origin. The reported cases
showed a geographical gradient, with the highest number found in the
North and the lowest number found in the South (p < 0.01). Hospitals
that were built before 1950 reported more legionellosis cases than did
those that were built later (p < 0.05).
Hospitals with a pavilion structure registered a higher number of
cases than did those with mixed or single-building structures
(p < 0.05) (Fig. 1). In particular, among the hospitals with pavilions, a
correlation was found between the number of pavilions and the number
of registered cases (ρ=0.44, p < 0.001). Higher numbers of cases
were also associated with the number of beds, wards, and operating
theaters (ρ=0.59, 0.51, 0.56, respectively; p < 0.001), and with the
presence of a cooling tower (p < 0.01) and maternity bathtubs
(p < 0.001).
Laboratory diagnosis was performed using urinary antigen testing
alone in 31.9% of the hospitals and using both urinary antigen testing
and single antibody titer in 17.8% of the hospitals. Seroconversion
[defined as a four-fold or greater increase in titer, after at least 20–30
days] was added in 21.5% of the hospitals. Culture-based or molecular
investigations were performed on 28.8% and 22.1% of the clinical
specimens, respectively. No laboratory investigation was reported by
16% of the hospitals, all with positive environmental cultures< 1000
cfu/L.
3.3. Environmental surveillance
The water systems were routinely tested for Legionella contamina-
tion in 97.4% of the hospitals, mostly with a 6-month frequency
(51.7%), and 62% of them detected a positive result (> 1000 cfu/L).
Each hospital established the number of water samples to be analyzed
considering the number of beds, according to Italian Guidelines (Linee,
2015). The methods used were culture-based investigation (97.3%),
molecular investigation (1.3%), or both (1.3%). The most frequent
strains resulted from Lpn sg 2–15 (58.4%), followed by Lpn sg 1
(31.5%) and Legionella species (L. micdadei, L. longbeachae, L. bozemanii)
(10.1%).
Investigations for airborne Legionella were conducted in 5.4% of the
hospitals, usually with annual (43.8%) or biannual (43.8%) frequency,
but no positive results appeared. The methods used were active sam-
pling (43.8%), settle plates (43.7%), or both (12.5%).
3.4. Control and preventive measures
Referrals were made to the 2015 national guidelines for the control
and prevention of legionellosis (Linee, 2015) by 55.2% of the hospitals.
Risk assessments were performed in 73% of the hospitals, and formally
dedicated multidisciplinary teams were present in 52.8% of the hospi-
tals. These teams mainly comprised hygienists (49.1%) and engineers
(49.1%). A prevention and control interventions manager was present
in 68.7% of the hospitals, and most hospitals had a register (79.8%), a
calendar (77.3%), and a checklist (75.5%) for the service work on the
water or air systems.
Measures to reduce the risk of legionellosis had been adopted in
93.3% of the hospitals, mostly through water system disinfection pro-
cedures (73.7%), cleaning (70.4%), or the replacement of taps and
showerheads (69.7%). The most commonly used water system disin-
fection procedures were thermal shock (37.4%), maintaining a constant
temperature from 55 °C to 60 °C (34.4%), and chlorine dioxide (34.4%).
Cooling towers were treated with antibacterial substances in 81.3% of
the hospitals, mostly using chlorine-based products (37.5%).
Training courses dedicated to the control and prevention of LD were
planned in 36.5% of the hospitals. Of these hospitals, 50.9% held these
courses once per year, 16.9% held them twice per year, and 32.2% held
them more than twice per year. These courses involved nurses (30.7%),
physicians (28.8%), biologists (21.5%), technicians (26.4%), and clea-
ners (11%).
4. Discussion
Hospitals represent a high-risk environment for LD transmission
because they frequently have old plumbing systems and medical
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devices used by hospitalized patients. In particular, recent surgery
(especially head and neck), nasogastric intubation, mechanical venti-
lation, and the use of respiratory therapy equipment have been iden-
tified as the main risk factors for nosocomial legionellosis (WHO,
2007).
In accordance with a national report (Rota et al., 2013), our study
showed the highest number of cases of legionellosis in Northern Italy.
Part of the reason for this geographic difference might be a greater
awareness about the risk of legionellosis among clinicians, greater at-
tention given to reporting cases of disease, and/or a more accurate
laboratory diagnosis in the North. It should be also noted that geo-
graphical variation in the LD incidence rate could be, in part, related to
the climate and meteorological conditions, as has been suggested for
other acute respiratory infections (Du Prel et al., 2009).
Overall, the patients were generally tested using only one of the
investigations recommended by the Italian guidelines (Linee, 2015),
usually the urinary antigen test, that unfortunately is sensitive only for
Lpn sg 1. For the other neglected serogroups and species, the applica-
tion of Legionella culture of sputum becomes most important even if it is
not widely performed (Lin et al., 2011; Pierre et al., 2017). Really, there
are some difficulties with diagnosing legionellosis (e.g., it is often not a
routine laboratory practice, urine antigen emission is not constant, the
antibody response is slow, in the early phase, the illness is often ac-
companied by a dry cough with little sputum). Therefore, it is necessary
to pay a great deal of attention to the laboratory tests. All specific tests
should ideally be performed for each patient with pneumonia, including
those who are seriously ill, whether or not they have clinical features
suggesting legionellosis. In fact, it has been shown that LD cannot be
excluded by a negative urine antigen or by a single low-titer serological
test (De Giglio et al., 2015; Montagna et al., 2006, 2014, 2016). It is
important to underline that the recovery of the isolate from the culture
of clinical samples, if compared with environmental strains through
molecular investigations, allows to identify the source of the infection
(Yu and Stout, 2009).
Tests for LD should also be performed for patients displaying
symptoms that do not match any other diagnosis, particularly for ill
patients who are aged over 40 years, immunosuppressed, or un-
responsive to beta-lactam antibiotics (WHO, 2007). It should be re-
membered that prevention measures are targeted to the prevention of
disease in both patients and health care personnel. Scientific evidence
has shown that hospital workers have an increased risk of contracting
legionellosis (Borella et al., 2008; Napoli et al., 2007).
Although previous work has found that Lpn sg 1 is the most
common isolate in humans, the present study found that the most fre-
quently isolated species was Legionella non-pneumophila 1, referred to as
Lpn sg 2–15. A large European study on 1335 strains isolated from
human cases showed that 33.9% of hospital-acquired infections were
caused by Legionella non-pneumophila 1 (Helbig et al., 2002). We think
that monovalent serotyping of the isolates should become a standard
procedure, because the pool of specific antisera for typing Lpn sg 2–15
is too large to obtain rigorous epidemiological data making it possible
to identify the source of the infection and to program the necessary
disinfection measures. Moreover, the isolation and identification of the
etiological agent is fundamental in planning a proper antimicrobial
therapy, particularly in severe cases. A more accurate analysis, in-
cluding antibiotic susceptibility, should be performed also on environ-
mental strains isolated during routine environmental surveillance. Past
work has demonstrated the importance of antimicrobial susceptibility
analysis of Legionella isolates for patients’ therapy and positive out-
comes and for reducing the direct costs associated with increasing
hospitalizations (De Giglio et al., 2015).
In terms of environmental surveillance, Italian hospitals demon-
strate a high level of attention to measures for the control and pre-
vention of legionellosis. The water systems are routinely tested, usually
with a 6-month frequency. However, culture-based investigations are
frequently the only action performed for surveillance. This finding is
not completely satisfactory. Scientific evidence has shown that the
simple measurement of colony-forming units does not give a real in-
dication of the infection risk or reveal the presence of all forms of
Legionella present in water systems (cells that are alive and viable, but
not culturable). The concentration of Legionella spp. in water systems is
not necessarily constant over time (Napoli et al., 2009), and it is im-
portant to evaluate the presence of Legionella regardless of the viable or
not viable status of the cells (Montagna et al., 2017b). Currently, rapid
and alternative molecular techniques can be used in combination with
culture-based techniques to specify and quantify Legionella in environ-
mental samples. Molecular methods, especially those based on Poly-
merase Chain Reaction, have important advantages, such as the ability
to provide results in a few hours, to detect all forms of Legionella (Lee
et al., 2011), and to perform epidemiological investigations (Yu and
Stout, 2009).
We also found that the detection of airborne Legionella was reported
to be conducted in only 5.4% of the participating hospitals. Although a
previous study showed that the detection of airborne Legionella cannot
replace water sampling because the absence of microorganisms in the
air does not necessarily mean that they are not present in the water, air
sampling may provide useful information for risk assessment
(Montagna et al., 2016, 2017b).
Regarding preventive and control measures, our study has demon-
strated that the adopted disinfection procedures for the water system
are mainly traditional methods (thermal shock and chlorination).
Following a recent study (Borella et al., 2016), we think that re-
mediation systems must be selected and adapted to the structural
characteristics of the hospital (e.g., age and type of construction, ma-
terial used for the water system), also considering the choice of an
appropriate cost-effective measure, to obtain the best effect with the
least damage to the pipes. Moreover, risk assessment—performed by
73% of the hospitals in our study—could be useful for predicting Le-
gionella spp. contamination in water systems. In fact, a validated and
standardized procedure of risk assessment has been demonstrated to be
useful for the rapid evaluation of the principal environmental risk
factors and for detecting Legionella spp. when it is present
(Hadjichristodoulou et al., 2006; Napoli et al., 2010). In this regard,
according to many countries legislation or guidelines, it might be useful
to incorporate the strategy to use the percentage of positive points to
define the risk of legionellosis in hospitals: if the percent of positive
environmental cultures at the distal sites is equal to or greater than 30%
of the total number sampled, than the disinfection of the water dis-
tribution system is appropriate (Allegheny County Health Department,
1997; Linee, 2015).
Our study has the limitation of being based on the voluntary par-
ticipation of a number of hospitals, and it is not sufficiently re-
presentative of Italy as a whole. For this reason, a further study needs to
be planned with larger participation, including different specialists,
particularly those who are new to the topic or who are collaborating in
a multidisciplinary team and need targeted knowledge.
5. Conclusions
The present study identifies the main features of actions taken for
legionellosis risk control and prevention in Italian hospitals. Greater
attention must be paid to hospitals with a pavilion structure and with
cooling towers, especially when these hospitals also have a larger
number of beds, wards and operating theaters, which are associated
with high numbers of cases of legionellosis. Risk analysis and en-
vironmental microbiological surveillance should be considered a
starting point for any prevention procedure. Moreover, laboratory
testing, both for diagnosis and for environmental purposes, should in-
clude molecular and antimicrobial assessments, as part of the risk as-
sessment. Finally, although national documents on the prevention of LD
are available, almost 50% of the investigated hospitals did not refer to
those documents, reflecting an underestimation of the importance of
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adequate risk analysis and management. Therefore, training courses for
health professionals targeted to the implementation of the existing
guidelines are still necessary at central and local levels.
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